- Home
- OVID vs DRCT Comparison
OVID vs DRCT Comparison
Compare OVID & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- DRCT
- Stock Information
- Founded
- OVID 2014
- DRCT 2018
- Country
- OVID United States
- DRCT United States
- Employees
- OVID N/A
- DRCT N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- DRCT Computer Software: Programming Data Processing
- Sector
- OVID Health Care
- DRCT Technology
- Exchange
- OVID Nasdaq
- DRCT Nasdaq
- Market Cap
- OVID 47.1M
- DRCT 38.7M
- IPO Year
- OVID 2017
- DRCT 2022
- Fundamental
- Price
- OVID $0.31
- DRCT $0.63
- Analyst Decision
- OVID Strong Buy
- DRCT Strong Buy
- Analyst Count
- OVID 6
- DRCT 1
- Target Price
- OVID $3.03
- DRCT $23.00
- AVG Volume (30 Days)
- OVID 343.6K
- DRCT 1.4M
- Earning Date
- OVID 03-11-2025
- DRCT 03-27-2025
- Dividend Yield
- OVID N/A
- DRCT N/A
- EPS Growth
- OVID N/A
- DRCT N/A
- EPS
- OVID N/A
- DRCT N/A
- Revenue
- OVID $566,000.00
- DRCT $62,288,000.00
- Revenue This Year
- OVID N/A
- DRCT N/A
- Revenue Next Year
- OVID $36.11
- DRCT $37.23
- P/E Ratio
- OVID N/A
- DRCT N/A
- Revenue Growth
- OVID 44.39
- DRCT N/A
- 52 Week Low
- OVID $0.31
- DRCT $0.51
- 52 Week High
- OVID $3.45
- DRCT $14.86
- Technical
- Relative Strength Index (RSI)
- OVID 22.55
- DRCT 40.92
- Support Level
- OVID $0.42
- DRCT $0.74
- Resistance Level
- OVID $0.48
- DRCT $1.46
- Average True Range (ATR)
- OVID 0.05
- DRCT 0.15
- MACD
- OVID -0.01
- DRCT 0.01
- Stochastic Oscillator
- OVID 1.73
- DRCT 11.82
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.